Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07140276 · ClinicalTrials.gov registry record · NA
An Integrated Substance Abuse-Domestic Violence (SADV) Treatment Outcome Study
A NA study of Substance Abuse and Domestic Violence, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT07140276: Completed NA study of Substance Abuse and Domestic Violence, sponsored by Yale University.
NCT07140276 is a NA study of Substance Abuse and Domestic Violence that has completed, run by Yale University. The registered enrollment target is 63 participants, below the 5,259-participant average among 58 other Substance Abuse trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07140276, a NA study of Substance Abuse and Domestic Violence, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will conduct a randomized trial comparing individual SADV to a manualized comparison condition that focuses on substance use only.
Primary Outcome
Days of substance use weekly from each participant endorsed as Y/N, by Self-report using time line follow back method, verified by alcohol concentration and urine toxicology
Conditions Studied
Interventions
- BEHAVIORAL Individual Therapy
- BEHAVIORAL Individual Drug Counseling manual
Study Locations (1)
Connecticut
- Yale New Haven Health System - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2007-07-03 |
| Est. Completion | 2010-06-30 |
| Phase | NA |
What the finished NCT07140276 record still lists
NCT07140276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 5,259-participant average among 58 other Substance Abuse trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Substance Abuse appearing as the primary indexed condition, and to 2 interventions - of which Individual Therapy is the first listed.
NCT07140276 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT07140276 about?
NCT07140276 is a clinical study titled "An Integrated Substance Abuse-Domestic Violence (SADV) Treatment Outcome Study". Investigators will conduct a randomized trial comparing individual SADV to a manualized comparison condition that focuses on substance use only.
What is the current status of trial NCT07140276?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2007-07-03. Estimated completion is 2010-06-30.
What conditions does trial NCT07140276 study?
This clinical trial studies the following conditions: Substance Abuse, Domestic Violence.
What interventions are being tested in trial NCT07140276?
The interventions under investigation include: Individual Therapy (BEHAVIORAL), Individual Drug Counseling manual (BEHAVIORAL).
Who is sponsoring clinical trial NCT07140276?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07140276 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07140276's enrollment target sits among peer trials
63 46th of 58 higher than 13 of 58 other Substance Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Testing ALERT With GTO in Middle Schools
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
The STop UNhealthy Substance Use Now Trial
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI